{"id":428247,"date":"2019-09-16T09:10:01","date_gmt":"2019-09-16T09:10:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=428247"},"modified":"2019-09-16T09:10:01","modified_gmt":"2019-09-16T09:10:01","slug":"nerve-regeneration-market-segmentation-latest-innovation-in-technology-growth-by-size-current-trends-global-share-and-regional-competitive-landscapes-forecast-to-2024","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/nerve-regeneration-market-segmentation-latest-innovation-in-technology-growth-by-size-current-trends-global-share-and-regional-competitive-landscapes-forecast-to-2024_428247.html","title":{"rendered":"Nerve Regeneration Market Segmentation, Latest Innovation in Technology Growth By Size, Current Trends, Global Share And Regional Competitive Landscapes, Forecast To 2024"},"content":{"rendered":"
\"Nerve<\/a><\/p>\n
\n
Nerve Regeneration Market<\/div>\n<\/div>\n<\/div>\n
Global Nerve Regeneration Market Research 2019 by Product, (Neurostimulation & Neuromodulation Devices and Biomaterials), by Application, (Neurostimulation and Neuromodulation Surgeries, Direct Nerve Repair\/Neurorrhaphy, Nerve Grafting, Stem Cell Therapy and others), by End User (Hospitals & Clinics, Ambulatory Surgery Centers and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2024<\/div>\n

The Global Nerve Regeneration Market was analyzed by Market Research Future (MRFR) and it was projected <\/strong>a CAGR of <\/strong>11.34%<\/strong> to reach USD <\/strong>12695.25 million by 2024. <\/strong>The valuation of the nerve regeneration market was further stated to surpass its previous valuation. <\/strong><\/p>\n

Market Overview<\/strong><\/p>\n

The Nerve Regeneration Market<\/a><\/strong> also comprises biomaterials like neuromodulator and neuro-stimulation devices. These are some of the biggest driving factors that are expected to push the growth of the market in the coming years. Peripheral nerves are connected directly to the brain as well as the spinal cord and other parts of the human body. These nerves are fragile in nature and can be easily damaged. This can therefore affect the brain’s ability to communicate with muscles or organs. However, lack of awareness among patients concerning nerve regeneration techniques can restrict the growth of the market.<\/p>\n

Competitive Landscape<\/strong><\/p>\n

The global nerve regeneration market comprises a host of key players. This includes names like Stryker Corporation (U.S.), Baxter International Inc. (U.S.), AxoGen Inc. (U.S.), Polyganics (the Netherlands), Boston Scientific Corporation (U.S.), Orthomed S.A.S. (France), Cyberonics Inc. (U.S.), Xcelthera, INC. (U.S), St. Jude Medical (U.S.), Integra Life Sciences Corporation (U.S.), Medtronic (U.S.), Neurotex Limited (U.K), and others.<\/strong><\/p>\n

Avail FREE Sample at: https:\/\/www.marketresearchfuture.com\/sample_request\/1202<\/a> <\/strong><\/p>\n

An expanding rate of geriatric population and the various benefits of regenerative surgeries compared to the painful conventional surgical methods are expected to boost the growth of the global market. The elderly population are more prone to suffer from chronic and neurological disorders like Alzheimer’s, Parkinson as compared to adults, thereby driving the growth of the market in a positive manner.<\/p>\n

The players operating in the global nerve regeneration market are focusing on product launches, along with expanding their global footprints by entering untapped markets.<\/p>\n